Company intelligence

Estuary Biotherapeutics

Last verified Oct 16, 2026

Key Metrics

Total funding
$103M
As of Oct 16, 2026FierceBiotech

Recent changes

  1. Oct 16, 2026Raised $40.7M SEC EDGAR Form D
  2. Oct 16, 2026Raised $93M Series A FierceBiotech
  3. Oct 16, 2026First reported total funding: $103M FierceBiotech
  4. Oct 16, 2026New investor: Google Ventures (GV) FierceBiotech
  5. Oct 16, 2026New investor: Deep Track Capital FierceBiotech
Earlier changes (2)
  1. Oct 16, 2026New investor: RA Capital FierceBiotech
  2. Oct 16, 2026Estuary Biotherapeutics Launches With $103M For Kidney Gene Therapy Pulse story

Funding History

2 events · sources dated per row
DateEventAmountValuationInvestorsSource
Oct 16, 2026funding round$40.7M—
SEC EDGAR Form D
Oct 16, 2026Series A$93M—
RA CapitalLeadunverifiedDeep Track CapitalunverifiedGoogle Ventures (GV)unverifiedBiogen New VenturesUPMC EnterprisesPivotal bioVenture PartnersNational Kidney Foundation Innovation Fund+1 more
FierceBiotech
Funding timeline · 2 rounds · $134M tracked
$0.0M$52M$104M$41MRoundOct 26$93MSeries AOct 26

Investors

Latest Pulse

  1. Biggest US Funding Rounds This Week: Modal's $750M LeadsCrunchbase's weekly ranking found just two U.S. rounds at or above $200M this week -- Modal Labs' $750M Series D and Icon's $200M Series D -- with investors otherwise sticking to the $60M-to-$135M range across AI, biotech and construction tech.→
  2. Estuary Biotherapeutics Launches With $103M For Kidney Gene TherapyEstuary Biotherapeutics emerged from stealth with $103 million, including a $93 million Series A led by RA Capital, to advance gene therapies for a common inherited kidney disease.→

Coverage Timeline

newest first
  1. Oct 16, 2026FUNDINGEstuary Biotherapeutics Launches With $103M For Kidney Gene Therapy$93M Series A ($103M Total)→

All Coverage

Related Companies

Estuary Biotherapeutics FAQ

How much has Estuary Biotherapeutics raised?

Estuary Biotherapeutics has raised $103M in total funding (As of Oct 16, 2026, FierceBiotech).

Who are Estuary Biotherapeutics's investors?

Estuary Biotherapeutics's investors include RA Capital, Deep Track Capital, Google Ventures (GV) (As of Oct 16, 2026).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction